Pricing Log in Create free account

Phathom Pharmaceuticals, Inc. (PHAT) vs Silence Therapeutics PLC Sponsored ADR (SLN)

Phathom Pharmaceuticals, Inc. and Silence Therapeutics PLC Sponsored ADR are both Biotechnology companies. Phathom Pharmaceuticals, Inc. and Silence Therapeutics PLC Sponsored ADR are of similar size ($606.8M and $581.1M). Phathom Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 110.2% against −97.0%. Silence Therapeutics PLC Sponsored ADR has the higher net margin (0.00% vs −41.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Phathom Pharmaceuticals, Inc. leads on 10 and Silence Therapeutics PLC Sponsored ADR on 5.

Valuation

Metric PHAT SLN Biotechnology median
P/E n/m n/m 8.50
P/S 2.42 488.70 9.71
P/B n/m 10.66 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.39 402.90 9.21
Earnings yield (18.50%) (14.75%) (33.15%)
Free cash flow yield (6.37%) (10.32%) (25.50%)

Profitability

Metric PHAT SLN Biotechnology median
Gross margin 82.92% 79.50% 65.16%
Operating margin (16.96%) 0.00% 0.00%
Net margin (41.34%) 0.00% 0.00%
Free cash flow margin (15.40%) 0.00% 0.00%
Return on equity 26.42% (90.41%) (56.36%)
Return on assets (34.32%) (44.14%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PHAT SLN Biotechnology median
Revenue growth (TTM) 110.16% (96.97%) 6.02%
EPS growth (last fiscal year) 42.72% (90.91%) 30.26%
Revenue growth, 5-year CAGR — (39.74%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PHAT SLN Biotechnology median
Debt to equity (0.48) 0.00 0.00
Current ratio 1.92 7.42 4.72
Net debt to EBITDA (0.51) 0.94 0.96

Dividend

Metric PHAT SLN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PHAT SLN Biotechnology median
Market cap 606.76m 581.10m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack